PGM3 Mutations Cause a Congenital Disorder of Glycosylation with Severe Immunodeficiency and Skeletal Dysplasia
Asbjørg Stray‐Pedersen(Baylor College of Medicine), I. Celine Hanson(Baylor College of Medicine), Jostein Westvik(Oslo University Hospital), Cecilie F. Rustad(University of Oslo), Tore G. Abrahamsen, Else Merckoll(Oslo University Hospital), Olaug K. Rødningen, Arild Rønnestad(Oslo University Hospital), Marcin W. Włodarski(St. Jude Children's Research Hospital), Magnar Bjørås(Oslo University Hospital), Kimiyo Raymond(Mayo Clinic in Arizona), Katja Benedikte Prestø Elgstøen(Oslo University Hospital), Hanne Sørmo Sorte(Oslo University Hospital), Caridad Martinez(Baylor College of Medicine), Gen Nishimura(Musashino University), Niti Chokshi(Baylor College of Medicine), Liv Osnes(Oslo University Hospital), Lars Mørkrid(Oslo University Hospital), Stephan Ehl(University Medical Center Freiburg), Eric Boerwinkle(Training Programs in Epidemiology and Public Health Interventions Network), Marcus Krüger(Centre Hospitalier Universitaire de Saint-Pierre), Shirley Abraham(University of New Mexico), Ghadir Sasa(Baylor College of Medicine), Jordan S. Orange(Children's Hospital of Philadelphia), Shalini N. Jhangiani(Baylor College of Medicine), Robert A. Krance(Baylor College of Medicine), Tomasz Gambin(Warsaw University of Technology), Christine R. Beck, Patricia Hall(Emory University), Paul Hoff Backe(Oslo University Hospital), Ekkehart Lausch(University Medical Center Freiburg), Ankita Patel(Gujarat University), Torstein Egeland(Oslo University Hospital), Lisa R. Forbes(Baylor College of Medicine), Hans Christian Erichsen(Oslo University Hospital), Donna M. Muzny(Baylor College of Medicine), James R. Lupski(Baylor College of Medicine), Richard A. Gibbs(Baylor College of Medicine), Carsten Speckmann(University of Freiburg)
Cited by 183
Related Papers
A global reference for human genetic variation
|Nature|2015|20.3k
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
Somatic mutations affect key pathways in lung adenocarcinoma
|Nature|2008|2.8k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k